Opus Genetics has announced positive topline results from LYNX-2, a clinical trial evaluating phentolamine ophthalmic solution 0.75% for the treatment of significant, chronic night

Sydney ophthalmologist Dr Michael Steiner has been honoured in the 2025 King’s Birthday List, with an appointment as a Member of the Order of

Research presented at the Association for Research in Vision and Ophthalmology annual meeting reveals a connection between mitochondrial disease and dementia risk.

Sylentis has released promising topline results from its Phase 2a study evaluating SYL1801, an eye drop therapy for the treatment of neovascular age-related macular